Egfr Tyrosine Kinase Inhibitors Versus Chemotherapy As First-Line Therapy For Non-Small Cell Lung Cancer Patients With The L858r Point Mutation (Vol 6, 36371, 2016)

Scientific Reports 6: Article number: 36371; published online: 04 November 2016; updated: 01 December 2016 In this Article, Haitang Yang is incorrectly listed as being affiliated with the ‘Department of Pathology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 230032, China’. The correct affiliation is listed below: Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 230032, China.